Healthcare
#NewAseBioMember | “AseBio is the perfect platform for company collaboration, research syn...
Meet Copal Scientific, our new member. We talked to its Mercedes Iriarte Cela, CEO.
#NewAseBioMember | “AseBio represents a platform within the bioindustry ecosystem”
Meet Spinally Medical, our new member. We talked to its Carles García-Vitoria, Co-fundador & Chief Scientific Officer.
ORYZON announces U.S. FDA clearance of CTEP-CRADA Phase I/II clinical trial sponsored by N...
In combination with either atezolizumab or durvalumab.
#AseBioID24 | "AseBio Investor Day is a unique meeting point for companies and investors s...
With the aim of analyzing the Spanish biotechnological ecosystem and delving into the challenges and opportunities it...
Revolution in Pain Management straight from Spain: Introducing the Spinally Medical
Spinally Medical introduces FuturaLead™, a subarachnoid device for spinal cord stimulation aimed at patients suffering...
Biotechnology lays the groundwork for the present and future of healthcare and drives the ...
The health pipeline of AseBio includes 130 molecules for 150 indications being investigated by 40 national companies...
Biotechnology lays the groundwork for the present and future of healthcare and drives the ...
AseBio's health pipeline includes 130 molecules for 150 indications being researched by 40 national companies, with...
The Spanish AI Healthcare Landscape
While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare...
ORYZON receives the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovati...
La compañía biofarmacéutica ya ha sido inscrita en el Registro de Público de PYMES INNOVADORAS.